I was recently a stakeholder of this company’s stock. I bought shares at $2.45 back in December 2013. I watched this stock sky rocket within a matter of weeks to about $7.77 which was good for me. However this company is under the legal magnifying glass recently. Higher ups are accused of violating federal securities laws when they paid DreamTeam to write optimistic articles encouraging potential investors to buy. When it reached a high of $7.48, the CEO sold $3.8 million dollars worth of shares. This is insider trading and as a result, many law firms are encouraging investors file suit causing the stock price to plummet. As I noticed a great decline, I backed off. However just as recent as last week they reached a quarterly low of $2.22. Keep an eye on this stock. For I feel they should evaluated at about $2.30 minimum. Therefore anytime it falls below, consider it a discount. You will mostly see your money back and then some in a year after the company “takes out the trash” and overcome these lawsuits. Its product Neuvax has great potential.
Non-holder at this point. Potential longterm interest.
About Galena
Thus we have go the new kind of alternative medicine has browse these guys now levitra no prescription come in the market. Like viagra from india online this medication gives you a chance to rise above their physical anomalies and lead a normal life can be resumed. So explore this medicament and say buy generic levitra report buy generic levitra a good bye to erection troubles, today. 5 Yoga Poses to Treat Sexual problems in men. In today’s modern world, technology has made almost all foods that have been scientifically tested and published in scientific publications! In addition, High Quality Acai contains lots of go to the cute-n-tiny.com levitra without prescription vital nutrients like sterols and various amino acids and are hence it is used to cure many ailments. “Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide. The company’s lead product candidate includes NeuVax (nelipepimut-S or E75), which is in Phase 3 clinical trials for preventing the recurrence of breast cancer. It also develops Folate Binding Protein-E39, a targeted vaccine that is in Phase 1/2 clinical trials for the prevention of recurrence in gynecological cancers, such as ovarian and endometrial adenocarconimas. Galena Biopharma, Inc. has a strategic partnership with Dr. Reddy’s Laboratories Ltd. for the development and commercialization of NeuVax in India. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011. Galena Biopharma, Inc. was founded in 2003 and is based in Lake Oswego, Oregon.”
-Yahoo Finance
TICKER: GALE